NO984462D0 - Sprayt°rkete mikropartikler som terapeutiske bµrere for bruk i genterapi - Google Patents

Sprayt°rkete mikropartikler som terapeutiske bµrere for bruk i genterapi

Info

Publication number
NO984462D0
NO984462D0 NO984462A NO984462A NO984462D0 NO 984462 D0 NO984462 D0 NO 984462D0 NO 984462 A NO984462 A NO 984462A NO 984462 A NO984462 A NO 984462A NO 984462 D0 NO984462 D0 NO 984462D0
Authority
NO
Norway
Prior art keywords
spray
gene therapy
dried microparticles
therapeutic carriers
carriers
Prior art date
Application number
NO984462A
Other languages
English (en)
Norwegian (no)
Other versions
NO984462L (no
Inventor
Andrew Derek Sutton
Jill Elizabeth Ogden
Richard Alan Johnson
Original Assignee
Andaris Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Andaris Ltd filed Critical Andaris Ltd
Publication of NO984462L publication Critical patent/NO984462L/no
Publication of NO984462D0 publication Critical patent/NO984462D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO984462A 1996-04-03 1998-09-25 Sprayt°rkete mikropartikler som terapeutiske bµrere for bruk i genterapi NO984462D0 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9607035.4A GB9607035D0 (en) 1996-04-03 1996-04-03 Spray-dried microparticles as therapeutic vehicles
GB9601379 1996-06-07
PCT/GB1997/000953 WO1997036578A1 (en) 1996-04-03 1997-04-03 Spray-dried microparticles as therapeutic vehicles for use in gene therapy

Publications (2)

Publication Number Publication Date
NO984462L NO984462L (no) 1998-09-25
NO984462D0 true NO984462D0 (no) 1998-09-25

Family

ID=26308516

Family Applications (1)

Application Number Title Priority Date Filing Date
NO984462A NO984462D0 (no) 1996-04-03 1998-09-25 Sprayt°rkete mikropartikler som terapeutiske bµrere for bruk i genterapi

Country Status (14)

Country Link
EP (1) EP0936902B1 (cg-RX-API-DMAC7.html)
JP (1) JP2000507568A (cg-RX-API-DMAC7.html)
AR (1) AR007493A1 (cg-RX-API-DMAC7.html)
AT (1) ATE243027T1 (cg-RX-API-DMAC7.html)
AU (1) AU715512B2 (cg-RX-API-DMAC7.html)
CA (1) CA2250478A1 (cg-RX-API-DMAC7.html)
DE (1) DE69722952T2 (cg-RX-API-DMAC7.html)
DK (1) DK0936902T3 (cg-RX-API-DMAC7.html)
ES (1) ES2201283T3 (cg-RX-API-DMAC7.html)
GB (1) GB9607035D0 (cg-RX-API-DMAC7.html)
NO (1) NO984462D0 (cg-RX-API-DMAC7.html)
PT (1) PT936902E (cg-RX-API-DMAC7.html)
WO (1) WO1997036578A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA972837B (cg-RX-API-DMAC7.html)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6051256A (en) 1994-03-07 2000-04-18 Inhale Therapeutic Systems Dispersible macromolecule compositions and methods for their preparation and use
JP2000500744A (ja) 1995-11-09 2000-01-25 マイクロバイオロジカル リサーチ オーソリティー ワクチン接種および遺伝子治療のためのマイクロカプセル化ｄｎａ
US6270795B1 (en) 1995-11-09 2001-08-07 Microbiological Research Authority Method of making microencapsulated DNA for vaccination and gene therapy
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US6946117B1 (en) 1997-09-29 2005-09-20 Nektar Therapeutics Stabilized preparations for use in nebulizers
US6433040B1 (en) 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
GB9810236D0 (en) 1998-05-13 1998-07-08 Microbiological Res Authority Improvements relating to encapsulation of bioactive agents
US6406719B1 (en) 1998-05-13 2002-06-18 Microbiological Research Authority Encapsulation of bioactive agents
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
TWI290473B (en) 2000-05-10 2007-12-01 Alliance Pharma Phospholipid-based powders for drug delivery
US7575761B2 (en) 2000-06-30 2009-08-18 Novartis Pharma Ag Spray drying process control of drying kinetics
AU2001291721A1 (en) * 2000-08-25 2002-03-04 Merck Patent G.M.B.H Powdered mannitol and mannitol-containing compositions
TWI324518B (en) 2001-12-19 2010-05-11 Nektar Therapeutics Pulmonary delivery of aminoglycosides
US9339459B2 (en) 2003-04-24 2016-05-17 Nektar Therapeutics Particulate materials
US7884085B2 (en) 2004-05-12 2011-02-08 Baxter International Inc. Delivery of AS-oligonucleotide microspheres to induce dendritic cell tolerance for the treatment of autoimmune type 1 diabetes
DK2072040T3 (da) 2004-05-12 2013-07-29 Baxter Healthcare Sa Terapeutisk anvendelse af nukleinsyremikrokugler
EP1834651A1 (en) * 2006-03-15 2007-09-19 Universiteit Gent Compositions and methods for veterinary vaccination
CA2942128C (en) 2006-08-04 2019-11-26 Baxter Healthcare S.A. Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes
US8808747B2 (en) 2007-04-17 2014-08-19 Baxter International Inc. Nucleic acid microparticles for pulmonary delivery
DE102009033196A1 (de) * 2009-07-14 2011-01-20 Beiersdorf Ag Kosmetische Zubereitung mit einem Gehalt an dispergierten Mikrosphären
EP3826608A1 (en) * 2018-07-23 2021-06-02 Translate Bio, Inc. Dry power formulations for messenger rna
EP3908264A1 (en) * 2019-01-09 2021-11-17 Ziccum AB Stabilized non-enveloped virus compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9107628D0 (en) * 1991-04-10 1991-05-29 Moonbrook Limited Preparation of diagnostic agents
ATE204750T1 (de) * 1992-06-12 2001-09-15 Teijin Ltd Pharmazeutische zubereitung zur anwendung in den atemwegen
ES2177544T3 (es) * 1992-06-12 2002-12-16 Teijin Ltd Polvo ultrafinno para inhalar y metodo para su preparacion.
WO1994023699A1 (en) * 1993-04-19 1994-10-27 Medisorb Technologies International L.P. Long-acting treatment by slow-release delivery of antisense oligodeoxyribonucleotides from biodegradable microparticles
ES2245780T3 (es) * 1994-05-18 2006-01-16 Nektar Therapeutics Metodos y composiciones para la formulacion de interferones como un polvo seco.
MX9702357A (es) * 1994-09-29 1997-06-28 Andaris Ltd Microparticulas secadas por aspersion como vehiculos terapeuticos.
WO1996027393A1 (en) * 1995-03-07 1996-09-12 University Of Pittsburgh A dry powder formulation for gene therapy
CA2227287A1 (en) * 1995-07-21 1997-02-06 Brown University Research Foundation A method for gene therapy using nucleic acid loaded polymeric microparticles

Also Published As

Publication number Publication date
CA2250478A1 (en) 1997-10-09
PT936902E (pt) 2003-11-28
WO1997036578A1 (en) 1997-10-09
AU2302097A (en) 1997-10-22
AU715512B2 (en) 2000-02-03
ES2201283T3 (es) 2004-03-16
ATE243027T1 (de) 2003-07-15
DK0936902T3 (da) 2003-10-06
EP0936902B1 (en) 2003-06-18
NO984462L (no) 1998-09-25
AR007493A1 (es) 1999-11-10
DE69722952T2 (de) 2003-12-11
JP2000507568A (ja) 2000-06-20
GB9607035D0 (en) 1996-06-05
EP0936902A1 (en) 1999-08-25
ZA972837B (en) 1998-04-03
DE69722952D1 (de) 2003-07-24

Similar Documents

Publication Publication Date Title
NO984462L (no) Sprayt°rkete mikropartikler som terapeutiske bµrere for bruk i genterapi
DK1212327T3 (da) Pyrazolopyrimidiner som terapeutiske midler
PL319600A1 (en) Spray-dried microparticles as therapeutic carriers
DK1637127T3 (da) Terapeutisk mikroskum
NO20002217L (no) Cyclopentan-heptansyre, 2-heteroarylalkenylderivater som terapeutiske midler
EE04528B1 (et) Teraapias kasutatavad spirofuropridiinide aralklamiinid
ID22878A (id) Komposisi aktif secara terapi
FI20000863A0 (fi) Uusi hoitomenetelmä
NO20022692L (no) Terapeutiske midler
DK1083934T3 (da) Genterapifremgangsmåder
DE60008752D1 (de) Selbstkühlende dose
ID23528A (id) Pengobatan terapeutik untuk gangguan kulit
PT1178981E (pt) 3-piridil-4-arilpirrois substituidos e metodos terapeuticos e profilacticos
ES1044983Y (es) Aparato de termoestimulacion para tratamientos terapeuticos.
NO20021976L (no) Selektiv leverterapi
NO20016301D0 (no) Terapeutiske midler
NO20023003L (no) Benzofenon-glykopyranosider, samt fremstilling og terapeutisk anvendelse
GB9911238D0 (en) Therapeutic use
ATE263089T1 (de) Selbstkühlende dose
IT235934Y1 (it) Perfezionamenti agli apparecchi stimolatori, in particolare per usoterapeutico
NO20003606L (no) Triazepinoner, fremgangsmÕte for deres fremstilling, samt deres terapeutiske anvendelse
GB9902139D0 (en) Therapeutic non-autologous proteins
GB9901794D0 (en) Therapeutic preparations
SI1212327T1 (en) Pyrazolopyrimidines as therapeutic agents
GB9926058D0 (en) Therapeutic proteins

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application